Advanced genetic engineering is already changing vaccine development and could make inroads into other branches of medicine. Pam Silver, the Elliott T. and Onie H. Adams Professor of Biochemistry and Systems Biology at HMS, presented at a meeting on synthetic biology at MIT over the weekend. Research by Douglas Melton, the Xander University Professor of Stem Cell and Regenerative Biology and co-director of the Harvard Stem Cell Institute, is also featured.
